this warrants ongoing monitoring No unexpected serious cardiovascular signals were identified during the limited Phase 2 follow-up period, though the trials were neither designed nor powered to assess cardiovascular outcomes, and longer-term data are not yet available At present, the overall safety profile appears broadly consistent with other GLP-1-based therapies, but definitive conclusions cannot be drawn until Phase 3 data and post-marketing surveillance are available
It can even offer some help to people living with kidney disease
He had lost about 16 pounds and, according to a DEXA scan, 3 percent of his body fat while maintaining most of his muscle
What Can Preclinical Sources Show About Redox Pathways
Cash-pay healthcare insights.
Tutti gli aggiornamenti su fitness, salute, alimentazione e benessere.